The drug “Lenacapavir” provides long-term protection and guarantees 100% protection against HIV infection
The American company Gilead Sciences, Inc. has conducted the first clinical trials of the last, third phase of its new drug for the human immunodeficiency virus (HIV) lenacapavir. And the medicine has shown absolute effectiveness: according to the manufacturer, this is the first medication in history that protects against HIV by 100%.